EXC.NASDAQExelon CORP

8-K: Exelon Settles Bribery Lawsuit, Boosts Governance

Sentiment:

Legal Settlement Announcement


Exelon Corporation has reached a $40 million settlement in a consolidated shareholder derivative lawsuit stemming from an alleged bribery scheme, implementing extensive corporate governance reforms and reducing a former CEO's compensation.

Summary

  • Exelon Corporation has agreed to a $40 million settlement in a consolidated shareholder derivative action, *In re Exelon Corporation Derivative Litigation*, which arose from an alleged eight-year bribery scheme by its subsidiary, Commonwealth Edison (ComEd).
  • The settlement includes a $40,000,000.00 USD monetary payment from Defendants' insurers to Exelon, with $30 million of these proceeds allocated to fund a portion of a separate $173 million securities settlement.
  • Exelon will implement robust corporate governance reforms, detailed in Exhibit A of the Stipulation, which will be maintained for a period of no less than five years from the effective date.
  • Former Exelon CEO Christopher M. Crane's 2020-2022 performance share award will be reduced by $4,249,809 USD to reflect the impact of the corporate fine from the 2020 Deferred Prosecution Agreement (DPA).
  • Plaintiffs' Counsel will receive a fee and expense award of $10,000,000.00 USD, subject to court approval, which will be paid from the $40 million settlement amount.
  • The settlement resolves all claims asserted in the consolidated derivative action and related demands, with all 'Released Claims' being dismissed with prejudice.
  • Claims against Anne Pramaggiore, Fidel Marquez, and John Hooker for clawbacks or recoupment of compensation and legal fees are explicitly not released by this settlement, with Exelon retaining the sole right to pursue them.

Sentiment

Score: 7

Explanation: The settlement resolves a significant legal and reputational issue, and the comprehensive governance reforms are a strong positive step towards preventing future misconduct. While the underlying issues were serious, the resolution and proactive measures indicate a commitment to improved corporate integrity. The financial impact is managed through insurance and a compensation reduction, rather than direct company cash flow.

Positives

  • The $40 million settlement payment from insurers to Exelon provides a direct financial benefit to the company, partially offsetting past liabilities.
  • The implementation of robust corporate governance reforms is expected to strengthen internal controls, compliance policies, and board oversight, reducing future risk.
  • The resolution of the consolidated derivative litigation removes a significant legal overhang and associated uncertainties, allowing the company to focus on its core business.
  • The reduction in former CEO Christopher M. Crane's performance share award demonstrates accountability for past misconduct.
  • The establishment of the Special Litigation Committee (SLC) and Independent Review Committee (IRC) ensured an independent and objective evaluation of the claims and settlement.

Negatives

  • The settlement includes a $10 million payment for Plaintiffs' Counsel fees and expenses, reducing the net benefit to Exelon from the $40 million insurance payment.
  • The underlying alleged bribery scheme and related misconduct highlight significant past governance and ethical failures within the company and its subsidiary.
  • The need for extensive corporate governance reforms indicates systemic issues that required external pressure to address.
  • The allocation of $30 million of the settlement proceeds to a separate securities settlement means a substantial portion of the funds are not available for other corporate uses.

Risks

  • The settlement does not release all claims, specifically retaining Exelon's right to pursue clawbacks and recoupment of legal fees against Anne Pramaggiore, Fidel Marquez, and John Hooker, indicating ongoing legal exposure related to these individuals.
  • The effectiveness of the new corporate governance reforms will depend on diligent implementation and continuous monitoring, with potential for future compliance failures if not rigorously enforced.
  • The company remains exposed to any claims asserted in the *Securities Action* (Flynn v. Exelon Corp.), which is subject to a separate settlement stipulation.
  • Reputational damage from the alleged bribery scheme and derivative litigation may persist, potentially impacting investor confidence and public perception.

Future Outlook

Exelon is committed to maintaining the newly adopted corporate governance reforms for a period of no less than five years from the effective date of the settlement. The Board will reassess and affirmatively determine whether certain prohibitions related to public official requests outweigh potential benefits at the end of the five-year period. The company retains the discretion to pursue certain unreleased claims against former executives Anne Pramaggiore, Fidel Marquez, and John Hooker after final adjudication of related criminal actions.

Management Comments

  • Plaintiffs and Plaintiffs' Counsel believe the claims asserted in the Consolidated Derivative Action have merit, but recognize the substantial time, expense, and uncertainty of continued litigation.
  • Plaintiffs and Plaintiffs' Counsel determined that the settlement is appropriate and in the best interests of the Company and its shareholders, conferring substantial and material benefits including corporate governance reforms.
  • Individual Defendants deny any and all allegations of fault, wrongdoing, liability, or damages, asserting they acted in good faith and in the best interests of Exelon and its shareholders.
  • Individual Defendants are entering the settlement to eliminate the burden, inconvenience, expense, uncertainty, and distraction of further litigation.
  • The Special Litigation Committee (SLC) unanimously approved the settlement, determining it is in the best interests of the Company.
  • The Independent Review Committee (IRC) unanimously accepted the SLC's recommendation and recommended Board approval, determining it is in the best interests of the Company.
  • The Board unanimously approved the settlement, accepting the IRC's determination and adopting the SLC's determination.

Industry Context

This settlement highlights the increasing scrutiny on corporate governance and ethical conduct within the utility sector, particularly concerning lobbying and political influence. The extensive reforms, including enhanced board oversight of political activities and stricter policies on interactions with public officials, reflect a broader industry trend towards greater transparency and accountability in response to regulatory pressures and public demand for ethical business practices. Companies in regulated industries are facing heightened expectations to prevent and address corruption, making robust compliance frameworks critical for maintaining public trust and operational licenses.

Comparison to Industry Standards

  • The implementation of a Special Litigation Committee (SLC) and an Independent Review Committee (IRC) to investigate and recommend settlement terms aligns with best practices for handling shareholder derivative actions, ensuring an independent assessment of claims.
  • The detailed corporate governance reforms, particularly those related to interactions with public officials, political contributions, and internal investigations, aim to bring Exelon's compliance framework in line with, or potentially exceed, evolving industry standards for ethical conduct in regulated sectors.
  • The clawback of executive compensation from former CEO Christopher M. Crane, and the retention of rights to pursue further clawbacks from other implicated individuals (Anne Pramaggiore, Fidel Marquez, John Hooker), reflects a growing trend in corporate governance to hold senior management accountable for misconduct, a standard increasingly expected by institutional investors and regulators.
  • The requirement for an outside audit review of the compliance program and culture, overseen by independent directors, is a strong measure that goes beyond basic compliance checks, aiming for a deeper cultural shift towards integrity, comparable to enhanced oversight mechanisms seen in other companies facing significant compliance challenges.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Board MemberAnn BerzinNew independent director with expertise in corporate ethics, management integrity, and compliance issuesBy 2023 annual meetingWill not seek reelection
Board MemberAnthony AndersonN/A (will not seek reelection)By 2024 annual meetingWill not seek reelection
Chair of Compensation CommitteeLinda JojoMarjorie Rodgers CheshireFollowing 2023 annual meetingWill roll off as Chair
Non-Executive Chair of the BoardJohn YoungNew Non-Executive ChairAfter 2025 annual meetingTerm as Chair will conclude
Board MemberN/AThree new independent directorsAs of June 9, 2023 (two appointed)Increase Board size as part of reforms

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy ReformAddition of language prohibiting 'rewarding' Public Officials to Section 3.1.1 of the Interactions with Public Officials Policy.Within 120 days of Effective DateStrengthens anti-corruption measures and clarifies ethical boundaries for interactions with government officials.
Policy ReformSupplementation of Employment Referral Policy to prohibit hiring candidates subject to known requests from Public Officials, clarify scope, and require independent director approval for exceptions (for 5 years).Within 120 days of Effective DateReduces potential for undue influence in hiring practices and enhances transparency, particularly concerning political connections.
Policy ReformSupplementation of Vendor Referral Policy to prohibit hiring vendors subject to known requests from Public Officials, with specific exceptions for critical services and independent director approval (for 5 years).Within 120 days of Effective DateMitigates risks of corruption and favoritism in vendor selection, ensuring decisions are based on merit and company interest.
Policy ReformAddition of provisions to Employment and Vendor Referral Policies deeming requests from lobbyists or political consultants as originating from Public Officials, requiring inquiry and reporting.Within 120 days of Effective DateCloses potential loopholes for indirect influence and increases accountability in reporting politically motivated requests.
Policy ReformInstitution of a policy prohibiting solicitation of political contributions from Company employees or officers on behalf of or to benefit any individual political campaigns and all non-Company PACs.Within 120 days of Effective DateReduces potential for coercion or perceived quid pro quo in political fundraising, enhancing ethical political engagement.
Oversight EnhancementCompliance and Audit Department to implement a documented process for monitoring material discretionary budgets (including CEO's) and analyze political contributions for impropriety, reporting biannually to the Audit Committee and Board.Within 120 days of Effective DateIncreases financial transparency and oversight of discretionary spending and political activities, reducing opportunities for misuse of funds.
Board OversightIncreased Board oversight of lobbying and political activity, including designating an existing Board Committee, receiving periodic reports from management, and approving semi-annual legislative strategies.Within 120 days of Effective DateEnsures strategic and ethical alignment of lobbying efforts with company values and regulatory compliance, with direct Board accountability.
Board ResponsibilityRevision of the Board Responsibility and Role section of the Corporate Governance Principles to explicitly add oversight of lobbying, political contributions, and political activities.Within 120 days of Effective DateFormally integrates political activity oversight into the Board's fiduciary duties, emphasizing its importance for corporate integrity.
Policy ReformImplementation of policies for internal investigations, including criteria for independent outside counsel, definition of 'Independent Outside Counsel,' and reporting requirements to the Audit Committee and Board.Within 120 days of Effective DateEnsures impartiality, thoroughness, and appropriate escalation of internal investigations, particularly for high-level misconduct.
Policy ReformConversion of Exelon's existing 'Clawback Policy' into a separate, standalone policy.Within 120 days of Effective DateEnhances the prominence and clarity of the clawback provisions, reinforcing accountability for misconduct affecting financial results.
Disclosure EnhancementEnhanced disclosure regarding the Board's oversight of the Company's legislative activity, pursuant to additional written policies.Within 120 days of Effective DateIncreases transparency for shareholders and the public regarding the company's political engagement and the Board's role in overseeing it.
Audit ReviewAn outside audit review of the compliance program and culture, including internal controls for lobbying and political activity, to be conducted by independent counsel and overseen by a special committee of independent directors.Within 120 days of Effective DateProvides an independent assessment of the effectiveness of compliance programs and fosters a culture of integrity, with direct oversight by disinterested directors.
Executive Compensation AlignmentAlignment of executive compensation with compliance with legal and ethical obligations, including the implementation of a negative modifier for failure to achieve certain compliance-related key performance indicators.Within 120 days of Effective DateDirectly links executive pay to ethical conduct and compliance performance, incentivizing a strong culture of integrity from the top.

Legal Proceedings

  • The Consolidated Derivative Action, *In re Exelon Corporation Derivative Litigation*, Case No. 21-cv-03611 (N.D. Ill.), which consolidated several shareholder derivative complaints (Clem, Nicosia, Coral Springs, Dybas, Raul actions) alleging breach of fiduciary duty, unjust enrichment, waste of corporate assets, and federal securities law violations related to an alleged bribery scheme.
  • The July 2020 Deferred Prosecution Agreement (DPA) entered into by Commonwealth Edison (ComEd) and the U.S. Attorneys' Office for the Northern District of Illinois, which is the basis for the derivative claims.
  • The Securities Action, *Flynn v. Exelon Corp.*, Case No. 1:19-cv-08209 (N.D. Ill.), a securities class action subject to a separate settlement stipulation, a portion of which will be funded by the current derivative settlement.
  • Ongoing claims against Anne Pramaggiore, Fidel Marquez, and John Hooker related to withholding/clawback of compensation and recoupment of legal fees, particularly in connection with *United States of America v. McClain, et al.*, Case No. 1:20-cr-00218 (N.D. Ill.).

Stakeholder Impact

  • **Shareholders**: Will benefit from the $40 million payment to the company (from insurers), the reduction of a former CEO's compensation, and significantly enhanced corporate governance and compliance measures, which aim to protect long-term value and reduce future legal risks. The settlement also resolves a major legal uncertainty.
  • **Employees**: Will be subject to new and clarified compliance policies, particularly regarding employment and vendor referrals and political contributions, fostering a more ethical work environment. The changes in management and board composition may also influence corporate culture.
  • **Customers**: May indirectly benefit from improved corporate ethics and governance, potentially leading to more transparent and fair business practices, though no direct impact on customer service or pricing is specified.
  • **Management/Directors**: Current management and directors will be responsible for implementing and adhering to the new governance reforms. Former CEO Christopher M. Crane faces a compensation reduction. Other implicated former executives (Pramaggiore, Marquez, Hooker) remain subject to potential clawback actions by the company.
  • **Regulators**: The settlement and extensive reforms demonstrate a response to regulatory scrutiny and the DPA, potentially improving relations with regulatory authorities and reducing the likelihood of future enforcement actions related to similar misconduct.

Next Steps

  • The United States District Court for the Northern District of Illinois will hold a Settlement Hearing on March 18, 2026, at 11:00 a.m. to consider final approval of the settlement.
  • Exelon will provide notice to shareholders, including publishing a short-form notice in Investor's Business Daily or similar publication, via a national wire service, and posting a long-form notice and settlement agreement on its Investor Relations website.
  • Exelon's Board will adopt, implement, and maintain the corporate governance reforms within 120 days of the Effective Date of the settlement.
  • Plaintiffs' Counsel will apply for Court-approved service awards for each Plaintiff, to be funded from the Fee and Expense Amount.
  • The Compliance and Audit Department will implement a documented process for monitoring material discretionary budgets and analyze political contributions, reporting findings to the Audit Committee and Board.
  • An outside audit review of the compliance program and culture will be conducted by independent counsel and overseen by a special committee of independent directors.

Key Dates

DateDescription
2020-03-20Earliest date Plaintiffs made pre-suit litigation demands on the Board.
2020-07Deferred Prosecution Agreement (DPA) entered into by Commonwealth Edison (ComEd) and the U.S. Attorneys' Office for the Northern District of Illinois.
2021-03Exelon's Board established the Special Litigation Committee (SLC).
2021-07-08James Clem filed the Clem Action, a shareholder derivative complaint.
2021-08-23William Grunze made a demand to inspect the company's corporate books and records.
2021-10-12Parties filed a joint motion for a temporary stay of the Clem Action, which the Court granted.
2022-01-04Benjamin Jason Wax made a demand to inspect the company's corporate books and records.
2022-01-31Start of period when parties filed additional joint motions to extend the temporary stay pending the SLC's investigation.
2022-03Board further delegated authority to the SLC to engage in mediation for settlement negotiations.
2022-05-03Latest date Plaintiffs made pre-suit litigation demands on the Board.
2022-07-19Board formed the Independent Review Committee (IRC).
2022-12-09End of period when parties filed additional joint motions to extend the temporary stay pending the SLC's investigation.
2023-03-09Exelon and Individual Defendants requested a 90-day extension of the temporary stay.
2023-03-27Court entered an order extending the temporary stay to June 9, 2023.
2023-04-24SLC, IRC, Exelon, Individual Defendants, and Plaintiffs Grunze, Wax, and Dybas reached agreement on settlement terms.
2023-04-25Mediation session held to negotiate attorneys' fees.
2023-04-26Donna Nicosia filed the Nicosia Action, a shareholder derivative complaint.
2023-05-01City of Coral Springs Police Officers' Pension Plan filed the Coral Springs Action. Term Sheet executed by Settling Parties.
2023-05-18SLC unanimously approved a resolution recommending the settlement.
2023-05-19IRC unanimously approved a resolution accepting the SLC's recommendation and recommending Board approval.
2023-05-22Board unanimously approved a resolution to enter the settlement. Judge Blakey granted motion to reassign Nicosia and Coral Springs actions.
2023-05-25Plaintiffs filed the Dybas Action, a shareholder derivative complaint.
2023-05-26SLC filed a notice of determination. Stipulation of Settlement filed in the Securities Action.
2023-05-30Plaintiffs moved the Court to reassign the Dybas Action to Judge Blakey.
2023-05-31SLC moved the Court to consolidate the Clem, Nicosia, Coral Springs, and Dybas Actions. Joint status report filed in the Clem Action.
2023-06-06Judge Blakey granted Plaintiffs' motion for reassignment of the Dybas Action and the SLC's motion to consolidate the four derivative actions.
2023-06-09Stipulation and Agreement of Settlement executed by Settling Parties. Date for record holders and beneficial owners of common stock to be affected by the settlement.
2023-10-11Pinchas Raul filed the Raul Action, a shareholder derivative complaint.
2023-11-14Judge Blakey granted motion to reassign and consolidate the Raul action.
2024Two current Board members (Ann Berzin and Anthony Anderson) will leave by the annual meeting.
2025John Young will remain Non-Executive Chair until the annual meeting, after which a new Non-Executive Chair will be appointed.
2025-11-18United States District Court for the Northern District of Illinois issued an order granting preliminary approval of the proposed settlement.
2025-11-24Date of the 8-K Current Report filing.
2026-03-04Deadline for shareholders to file written objections to the settlement (14 calendar days before the Settlement Hearing).
2026-03-18Settlement Hearing at 11:00 a.m. before Judge John Robert Blakey to determine final approval of the settlement.

Recommendation

hold

The settlement of a significant shareholder derivative lawsuit and the implementation of comprehensive corporate governance reforms are positive developments that remove a major legal overhang and address past misconduct. These actions should improve investor confidence in Exelon's long-term integrity and risk management. However, the underlying issues of bribery and ethical lapses were severe, and the full impact of the reforms will take time to materialize. While the resolution is favorable, it primarily addresses past problems rather than signaling new growth opportunities. Therefore, a 'hold' recommendation is appropriate, acknowledging the positive steps taken while awaiting evidence of sustained improvement in operational and ethical performance.

Keywords

Exelon, Derivative Litigation, Settlement, Corporate Governance, Bribery Scheme, SEC Filing, ComEd, Deferred Prosecution Agreement, Shareholder Lawsuit, Compliance Reforms, Executive Compensation, Risk Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.